Search results
1 day ago · The late Laura Ziskin and the late Noreen Fraser are also co-founders. Julian Adams, Ph.D., serves as SU2C’s president and CEO. For more information visit StandUpToCancer.org , Instagram , TikTok , Twitter , Facebook , and YouTube .
3 days ago · Breast Cancer. Results from the ... III epidermal growth factor receptor-mutated (EGFRm) NSCLC: Primary results of the phase 3 LAURA study. ASCO 2024. May 31 – June 4, 2024. Abstract LBA4. ...
1 day ago · Background Cancer stem-like cells (CSCs) have been extensively researched as the primary drivers of therapy resistance and tumor relapse in patients with breast cancer. However, due to lack of specific molecular markers, increased phenotypic plasticity and no clear clinicopathological features, the assessment of CSCs presence and functionality in solid tumors is challenging. While several ...
2 days ago · About the Breast Cancer Now Toby Robins Research Centre at The Institute of Cancer Research, ... please contact Laura Milne in the ICR press office on 0203 437 3517 or laura.milne@icr.ac.uk. For ...
8 hours ago · Laura Ingraham is a conservative television host who fronts Fox News Channel’s program The Ingraham Angle. ... she did not go ahead with the wedding due to her breast cancer diagnosis and ...
5 days ago · Prostaglandin E2 (PGE2) is well known to promote tumor progression by boosting cancer cell proliferation while inhibiting anticancer immunity. Recent data from Lacher et al. and Morotti et al. demonstrate that one of the mechanisms through which PGE2 suppresses tumor-targeting immune responses involves downregulation of interleukin 2 (IL2 ...
2 days ago · The LAURA trial is the first phase 3 study to assess a targeted agent in patients with unresectable stage III NSCLC. It included a total of 216 patients from 17 countries randomly assigned 2:1 to receive either osimertinib (143 patients) or placebo (73) patients. The majority of patients in the study were female (63% in the osimertinib group ...
